Meet the outliers

We're one of the most active early-stage VC investors in the US. What do we invest in? Great companies. No matter what they do, or where, or how. Take a look at our portfolio of 190+ companies, and see for yourself.

Janux

Biopharma

Trefoil

Biopharma
ipo

Synthoryx

Biopharma
acquired

RQx Pharmaceuticals

Biopharma

Qlaris

Biopharma
acquired

Lexent Bio

Biopharma
ipo

Galera

Biopharma

Ankasa

Biopharma

Anexigen

Biopharma

Scout Bio

Biopharma
ipo

ORIC

Biopharma